Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

Gelder, M. van; Ziagkos, D.; Wreede, L. de; Biezen, A. van; Dreger, P.; Gramatzki, M.; ... ; European Soc Blood Marrow Transpla (2017)

Article / Letter to editor

• del(17p)
• HLA-matched donor
• Kinase- and BCL2 inhibitor refractory
• Non-relapse mortality
• Risk factor analysis

• All authors: Gelder, M. van; Ziagkos, D.; Wreede, L. de; Biezen, A. van; Dreger, P.; Gramatzki, M.; Stelljes, M.; Andersen, N.S.; Schaap, N.; Vitek, A.; Beelen, D.; Lindstrom, V.; Finke, J.; Passweg, J.; Eder, M.; Machaczka, M.; Delgado, J.; Kruger, W.; Raida, L.; Socie, G.; Jindra, P.; Afanasyev, B.; Wagner, E.; Chalandon, Y.; Henseler, A.; Schoenland, S.; Kroger, N.; Schetelig, J.; CLL Subcomm Chronic Malignancies W; European Soc Blood Marrow Transpla
• Date: 2017-10-31
• Journal: Clinical Lymphoma, Myeloma and Leukemia
• Volume: 17
• Issue: 10
• Pages: 667 - +
• DOI: doi:10.1016/j.clml.2017.06.007